ロード中...
Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells
Raloxifene hydrochloride (RAL), one of second generation of selective estrogen receptor modulators (SERMs), is usually used in preventing osteoporosis and breast cancer. The present study evaluated whether Raloxifene might sensitize multidrug resistant (MDR) breast cancers to chemotherapies, especia...
保存先:
| 出版年: | Cancer Biol Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847829/ https://ncbi.nlm.nih.gov/pubmed/26529585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1095409 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|